
A REIT With Great V...


| Price and Volume | |
|---|---|
| Recent Price | 7.92 |
| 52 Week High | 13.50 |
| 52 Week Low | 6.01 |
| Avg. Daily Vol. (Mil) | 5.35 |
| Beta (3 year) | -0.54 |
| Share Related Items | |
| Mkt Cap (Mil) | 1,724.79 |
| Shares Out (Mil) | 217.78 |
| Float (Mil) | 216.55 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 5.10 |
| Current Ratio | 5.50 |
| LT Debt/ Equity | 0.90 |
| Total Debt / Equity | 0.92 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 62.11 |
| Price/Book | 21.45 |
| Price/Cash Flow | -25.70 |
| Per Share Data | |
| Earnings | -0.38 |
| Sales | 0.13 |
| Book Value | 0.37 |
| Cash Flow | -0.31 |
| Business Summary | |
|---|---|
| Arena Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing novel drugs that target G protein-coupled receptors to address major therapeutic areas like cardiovascular & metabolic diseases. | |
| General Information | |
| 6154 Nancy Ridge Drive
San Diego, CA 92121 |
|
| www.arenapharm.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 293 | |
| CEO: Jack Lief | |
| Short Interest | |
| Current Month (Mil) | 59.31 |
| Previous Month (Mil) | 62.30 |
| Short Interest Ratio (Days) | 15.60 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -32.90 |
| Return on Investments | -50.00 |
| Profitability | |
| Gross Margin | 82.00 |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |